205 related articles for article (PubMed ID: 21425247)
1. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.
Elkayam O; Amir S; Mendelson E; Schwaber M; Grotto I; Wollman J; Arad U; Brill A; Paran D; Levartovsky D; Wigler I; Caspi D; Mandelboim M
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1062-7. PubMed ID: 21425247
[TBL] [Abstract][Full Text] [Related]
2. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
Mathian A; Devilliers H; Krivine A; Costedoat-Chalumeau N; Haroche J; Huong DB; Wechsler B; Hervier B; Miyara M; Morel N; Le Corre N; Arnaud L; Piette JC; Musset L; Autran B; Rozenberg F; Amoura Z
Arthritis Rheum; 2011 Nov; 63(11):3502-11. PubMed ID: 21811996
[TBL] [Abstract][Full Text] [Related]
4. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease.
Aikawa NE; Campos LM; Silva CA; Carvalho JF; Saad CG; Trudes G; Duarte A; Miraglia JL; Timenetsky Mdo C; Viana VS; França IL; Bonfa E; Pereira RM
J Rheumatol; 2012 Jan; 39(1):167-73. PubMed ID: 22089462
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
[TBL] [Abstract][Full Text] [Related]
8. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
[TBL] [Abstract][Full Text] [Related]
9. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
Ribeiro AC; Guedes LK; Moraes JC; Saad CG; Aikawa NE; Calich AL; França IL; Carvalho JF; Sampaio-Barros PD; Goncalves CR; Borba EF; Timenetsky Mdo C; Precioso AR; Duarte A; Bonfa E; Laurindo IM
Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
13. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
Borba EF; Saad CG; Pasoto SG; Calich AL; Aikawa NE; Ribeiro AC; Moraes JC; Leon EP; Costa LP; Guedes LK; Silva CA; Goncalves CR; Fuller R; Oliveira SA; Ishida MA; Precioso AR; Bonfa E
Rheumatology (Oxford); 2012 Jun; 51(6):1061-9. PubMed ID: 22298793
[TBL] [Abstract][Full Text] [Related]
14. Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.
Ribeiro AC; Laurindo IM; Guedes LK; Saad CG; Moraes JC; Silva CA; Bonfa E
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):476-80. PubMed ID: 22949223
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis.
Dell'Era L; Corona F; Daleno C; Scala A; Principi N; Esposito S
Vaccine; 2012 Jan; 30(5):936-40. PubMed ID: 22138210
[TBL] [Abstract][Full Text] [Related]
16. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
17. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
[TBL] [Abstract][Full Text] [Related]
20. Response to a monovalent 2009 influenza A (H1N1) vaccine.
Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
